Global Metagenomics in Healthcare Market 2021 by Company, Regions, Type and Application, ...

  • Report ID:57365
  • Industry Name: Medical Care
  • Publishing Date: May-21
  • No. of Pages: 101
                              
The Metagenomics in Healthcare market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest research, the global Metagenomics in Healthcare size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Metagenomics in Healthcare market size is expected to grow at a CAGR of xx% for the next five years. Market segmentation Metagenomics in Healthcare market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type, covers Sample Extraction Kits Metagenomics Kits Market segment by Application, can be divided into Pharmaceutical Industries Biotechnology Companies Pathology Laboratories Academic and Research Laboratories Others Market segment by players, this report covers Illumina QIAGEN PerkinElmer Thermo Fisher Scientific Oxford Nanopore Technologies Market segment by regions, regional analysis covers North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific) South America (Brazil, Argentina, Rest of South America) Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
                        
1 Market Overview 1.1 Product Overview and Scope of Metagenomics in Healthcare 1.2 Classification of Metagenomics in Healthcare by Type 1.2.1 Overview: Global Metagenomics in Healthcare Market Size by Type: 2020 Versus 2021 Versus 2026 1.2.2 Global Metagenomics in Healthcare Revenue Market Share by Type in 2020 1.2.3 Sample Extraction Kits 1.2.4 Metagenomics Kits 1.3 Global Metagenomics in Healthcare Market by Application 1.3.1 Overview: Global Metagenomics in Healthcare Market Size by Application: 2020 Versus 2021 Versus 2026 1.3.2 Pharmaceutical Industries 1.3.3 Biotechnology Companies 1.3.4 Pathology Laboratories 1.3.5 Academic and Research Laboratories 1.3.6 Others 1.4 Global Metagenomics in Healthcare Market Size & Forecast 1.5 Global Metagenomics in Healthcare Market Size and Forecast by Region 1.5.1 Global Metagenomics in Healthcare Market Size by Region: 2016 VS 2021 VS 2026 1.5.2 Global Metagenomics in Healthcare Market Size by Region, (2016-2021) 1.5.3 North America Metagenomics in Healthcare Market Size and Prospect (2016-2026) 1.5.4 Europe Metagenomics in Healthcare Market Size and Prospect (2016-2026) 1.5.5 Asia-Pacific Metagenomics in Healthcare Market Size and Prospect (2016-2026) 1.5.6 South America Metagenomics in Healthcare Market Size and Prospect (2016-2026) 1.5.7 Middle East and Africa Metagenomics in Healthcare Market Size and Prospect (2016-2026) 1.6 Market Drivers, Restraints and Trends 1.6.1 Metagenomics in Healthcare Market Drivers 1.6.2 Metagenomics in Healthcare Market Restraints 1.6.3 Metagenomics in Healthcare Trends Analysis 2 Company Profiles 2.1 Illumina 2.1.1 Illumina Details 2.1.2 Illumina Major Business 2.1.3 Illumina Metagenomics in Healthcare Product and Solutions 2.1.4 Illumina Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2019-2021) 2.1.5 Illumina Recent Developments and Future Plans 2.2 QIAGEN 2.2.1 QIAGEN Details 2.2.2 QIAGEN Major Business 2.2.3 QIAGEN Metagenomics in Healthcare Product and Solutions 2.2.4 QIAGEN Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2019-2021) 2.2.5 QIAGEN Recent Developments and Future Plans 2.3 PerkinElmer 2.3.1 PerkinElmer Details 2.3.2 PerkinElmer Major Business 2.3.3 PerkinElmer Metagenomics in Healthcare Product and Solutions 2.3.4 PerkinElmer Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2019-2021) 2.3.5 PerkinElmer Recent Developments and Future Plans 2.4 Thermo Fisher Scientific 2.4.1 Thermo Fisher Scientific Details 2.4.2 Thermo Fisher Scientific Major Business 2.4.3 Thermo Fisher Scientific Metagenomics in Healthcare Product and Solutions 2.4.4 Thermo Fisher Scientific Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2019-2021) 2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans 2.5 Oxford Nanopore Technologies 2.5.1 Oxford Nanopore Technologies Details 2.5.2 Oxford Nanopore Technologies Major Business 2.5.3 Oxford Nanopore Technologies Metagenomics in Healthcare Product and Solutions 2.5.4 Oxford Nanopore Technologies Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2019-2021) 2.5.5 Oxford Nanopore Technologies Recent Developments and Future Plans 3 Market Competition, by Players 3.1 Global Metagenomics in Healthcare Revenue and Share by Players (2019-2021) 3.2 Market Concentration Rate 3.2.1 Top 3 Metagenomics in Healthcare Players Market Share 3.2.2 Top 10 Metagenomics in Healthcare Players Market Share 3.2.3 Market Competition Trend 3.3 Metagenomics in Healthcare Players Head Office, Products and Services Provided 3.4 Mergers & Acquisitions 3.5 New Entrants and Expansion Plans 4 Market Size Segment by Type 4.1 Global Metagenomics in Healthcare Revenue and Market Share by Type (2016-2021) 4.2 Global Metagenomics in Healthcare Market Forecast by Type (2021-2026) 5 Market Size Segment by Application 5.1 Global Metagenomics in Healthcare Revenue Market Share by Application (2016-2021) 5.2 Metagenomics in Healthcare Market Forecast by Application (2021-2026) 6 North America by Country, by Type, and by Application 6.1 North America Metagenomics in Healthcare Revenue by Type (2016-2026) 6.2 North America Metagenomics in Healthcare Revenue by Application (2016-2026) 6.3 North America Metagenomics in Healthcare Market Size by Country 6.3.1 North America Metagenomics in Healthcare Revenue by Country (2016-2026) 6.3.2 United States Metagenomics in Healthcare Market Size and Forecast (2016-2026) 6.3.3 Canada Metagenomics in Healthcare Market Size and Forecast (2016-2026) 6.3.4 Mexico Metagenomics in Healthcare Market Size and Forecast (2016-2026) 7 Europe by Country, by Type, and by Application 7.1 Europe Metagenomics in Healthcare Revenue by Type (2016-2026) 7.2 Europe Metagenomics in Healthcare Revenue by Application (2016-2026) 7.3 Europe Metagenomics in Healthcare Market Size by Country 7.3.1 Europe Metagenomics in Healthcare Revenue by Country (2016-2026) 7.3.2 Germany Metagenomics in Healthcare Market Size and Forecast (2016-2026) 7.3.3 France Metagenomics in Healthcare Market Size and Forecast (2016-2026) 7.3.4 United Kingdom Metagenomics in Healthcare Market Size and Forecast (2016-2026) 7.3.5 Russia Metagenomics in Healthcare Market Size and Forecast (2016-2026) 7.3.6 Italy Metagenomics in Healthcare Market Size and Forecast (2016-2026) 8 Asia-Pacific by Region, by Type, and by Application 8.1 Asia-Pacific Metagenomics in Healthcare Revenue by Type (2016-2026) 8.2 Asia-Pacific Metagenomics in Healthcare Revenue by Application (2016-2026) 8.3 Asia-Pacific Metagenomics in Healthcare Market Size by Region 8.3.1 Asia-Pacific Metagenomics in Healthcare Revenue by Region (2016-2026) 8.3.2 China Metagenomics in Healthcare Market Size and Forecast (2016-2026) 8.3.3 Japan Metagenomics in Healthcare Market Size and Forecast (2016-2026) 8.3.4 South Korea Metagenomics in Healthcare Market Size and Forecast (2016-2026) 8.3.5 India Metagenomics in Healthcare Market Size and Forecast (2016-2026) 8.3.6 Southeast Asia Metagenomics in Healthcare Market Size and Forecast (2016-2026) 8.3.7 Australia Metagenomics in Healthcare Market Size and Forecast (2016-2026) 9 South America by Country, by Type, and by Application 9.1 South America Metagenomics in Healthcare Revenue by Type (2016-2026) 9.2 South America Metagenomics in Healthcare Revenue by Application (2016-2026) 9.3 South America Metagenomics in Healthcare Market Size by Country 9.3.1 South America Metagenomics in Healthcare Revenue by Country (2016-2026) 9.3.2 Brazil Metagenomics in Healthcare Market Size and Forecast (2016-2026) 9.3.3 Argentina Metagenomics in Healthcare Market Size and Forecast (2016-2026) 10 Middle East & Africa by Country, by Type, and by Application 10.1 Middle East & Africa Metagenomics in Healthcare Revenue by Type (2016-2026) 10.2 Middle East & Africa Metagenomics in Healthcare Revenue by Application (2016-2026) 10.3 Middle East & Africa Metagenomics in Healthcare Market Size by Country 10.3.1 Middle East & Africa Metagenomics in Healthcare Revenue by Country (2016-2026) 10.3.2 Turkey Metagenomics in Healthcare Market Size and Forecast (2016-2026) 10.3.3 Saudi Arabia Metagenomics in Healthcare Market Size and Forecast (2016-2026) 10.3.4 UAE Metagenomics in Healthcare Market Size and Forecast (2016-2026) 11 Research Findings and Conclusion 12 Appendix 12.1 Methodology 12.2 Research Process and Data Source 12.3 Disclaimer
                
List of Tables Table 1. Global Metagenomics in Healthcare Revenue by Type, (USD Million), 2020 VS 2021 VS 2026 Table 2. Global Metagenomics in Healthcare Revenue by Application, (USD Million), 2020 VS 2021 VS 2026 Table 3. Global Market Metagenomics in Healthcare Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026) Table 4. Global Metagenomics in Healthcare Revenue (USD Million) by Region (2016-2021) Table 5. Global Metagenomics in Healthcare Revenue Market Share by Region (2021-2026) Table 6. Illumina Corporate Information, Head Office, and Major Competitors Table 7. Illumina Major Business Table 8. Illumina Metagenomics in Healthcare Product and Solutions Table 9. Illumina Metagenomics in Healthcare Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 10. QIAGEN Corporate Information, Head Office, and Major Competitors Table 11. QIAGEN Major Business Table 12. QIAGEN Metagenomics in Healthcare Product and Solutions Table 13. QIAGEN Metagenomics in Healthcare Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 14. PerkinElmer Corporate Information, Head Office, and Major Competitors Table 15. PerkinElmer Major Business Table 16. PerkinElmer Metagenomics in Healthcare Product and Solutions Table 17. PerkinElmer Metagenomics in Healthcare Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 18. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors Table 19. Thermo Fisher Scientific Major Business Table 20. Thermo Fisher Scientific Metagenomics in Healthcare Product and Solutions Table 21. Thermo Fisher Scientific Metagenomics in Healthcare Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 22. Oxford Nanopore Technologies Corporate Information, Head Office, and Major Competitors Table 23. Oxford Nanopore Technologies Major Business Table 24. Oxford Nanopore Technologies Metagenomics in Healthcare Product and Solutions Table 25. Oxford Nanopore Technologies Metagenomics in Healthcare Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 26. Global Metagenomics in Healthcare Revenue (USD Million) by Players (2019-2021) Table 27. Global Metagenomics in Healthcare Revenue Share by Players (2019-2021) Table 28. Breakdown of Metagenomics in Healthcare by Company Type (Tier 1, Tier 2 and Tier 3) Table 29. Metagenomics in Healthcare Players Head Office, Products and Services Provided Table 30. Metagenomics in Healthcare Mergers & Acquisitions in the Past Five Years Table 31. Metagenomics in Healthcare New Entrants and Expansion Plans Table 32. Global Metagenomics in Healthcare Revenue (USD Million) by Type (2016-2021) Table 33. Global Metagenomics in Healthcare Revenue Share by Type (2016-2021) Table 34. Global Metagenomics in Healthcare Revenue Forecast by Type (2021-2026) Table 35. Global Metagenomics in Healthcare Revenue by Application (2016-2021) Table 36. Global Metagenomics in Healthcare Revenue Forecast by Application (2021-2026) Table 37. North America Metagenomics in Healthcare Revenue by Type (2016-2021) & (USD Million) Table 38. North America Metagenomics in Healthcare Revenue by Type (2021-2026) & (USD Million) Table 39. North America Metagenomics in Healthcare Revenue by Application (2016-2021) & (USD Million) Table 40. North America Metagenomics in Healthcare Revenue by Application (2021-2026) & (USD Million) Table 41. North America Metagenomics in Healthcare Revenue by Country (2016-2021) & (USD Million) Table 42. North America Metagenomics in Healthcare Revenue by Country (2021-2026) & (USD Million) Table 43. Europe Metagenomics in Healthcare Revenue by Type (2016-2021) & (USD Million) Table 44. Europe Metagenomics in Healthcare Revenue by Type (2021-2026) & (USD Million) Table 45. Europe Metagenomics in Healthcare Revenue by Application (2016-2021) & (USD Million) Table 46. Europe Metagenomics in Healthcare Revenue by Application (2021-2026) & (USD Million) Table 47. Europe Metagenomics in Healthcare Revenue by Country (2016-2021) & (USD Million) Table 48. Europe Metagenomics in Healthcare Revenue by Country (2021-2026) & (USD Million) Table 49. Asia-Pacific Metagenomics in Healthcare Revenue by Type (2016-2021) & (USD Million) Table 50. Asia-Pacific Metagenomics in Healthcare Revenue by Type (2021-2026) & (USD Million) Table 51. Asia-Pacific Metagenomics in Healthcare Revenue by Application (2016-2021) & (USD Million) Table 52. Asia-Pacific Metagenomics in Healthcare Revenue by Application (2021-2026) & (USD Million) Table 53. Asia-Pacific Metagenomics in Healthcare Revenue by Region (2016-2021) & (USD Million) Table 54. Asia-Pacific Metagenomics in Healthcare Revenue by Region (2021-2026) & (USD Million) Table 55. South America Metagenomics in Healthcare Revenue by Type (2016-2021) & (USD Million) Table 56. South America Metagenomics in Healthcare Revenue by Type (2021-2026) & (USD Million) Table 57. South America Metagenomics in Healthcare Revenue by Application (2016-2021) & (USD Million) Table 58. South America Metagenomics in Healthcare Revenue by Application (2021-2026) & (USD Million) Table 59. South America Metagenomics in Healthcare Revenue by Country (2016-2021) & (USD Million) Table 60. South America Metagenomics in Healthcare Revenue by Country (2021-2026) & (USD Million) Table 61. Middle East & Africa Metagenomics in Healthcare Revenue by Type (2016-2021) & (USD Million) Table 62. Middle East & Africa Metagenomics in Healthcare Revenue by Type (2021-2026) & (USD Million) Table 63. Middle East & Africa Metagenomics in Healthcare Revenue by Application (2016-2021) & (USD Million) Table 64. Middle East & Africa Metagenomics in Healthcare Revenue by Application (2021-2026) & (USD Million) Table 65. Middle East & Africa Metagenomics in Healthcare Revenue by Country (2016-2021) & (USD Million) Table 66. Middle East & Africa Metagenomics in Healthcare Revenue by Country (2021-2026) & (USD Million) List of Figures Figure 1. Metagenomics in Healthcare Picture Figure 2. Global Metagenomics in Healthcare Revenue Market Share by Type in 2020 Figure 3. Sample Extraction Kits Figure 4. Metagenomics Kits Figure 5. Metagenomics in Healthcare Revenue Market Share by Application in 2020 Figure 6. Pharmaceutical Industries Picture Figure 7. Biotechnology Companies Picture Figure 8. Pathology Laboratories Picture Figure 9. Academic and Research Laboratories Picture Figure 10. Others Picture Figure 11. Global Metagenomics in Healthcare Revenue, (USD Million): 2020 VS 2021 VS 2026 Figure 12. Global Metagenomics in Healthcare Revenue and Forecast (2016-2026) & (USD Million) Figure 13. Global Metagenomics in Healthcare Revenue Market Share by Region (2016-2026) Figure 14. Global Metagenomics in Healthcare Revenue Market Share by Region in 2020 Figure 15. North America Metagenomics in Healthcare Revenue (USD Million) and Growth Rate (2016-2026) Figure 16. Europe Metagenomics in Healthcare Revenue (USD Million) and Growth Rate (2016-2026) Figure 17. Asia-Pacific Metagenomics in Healthcare Revenue (USD Million) and Growth Rate (2016-2026) Figure 18. South America Metagenomics in Healthcare Revenue (USD Million) and Growth Rate (2016-2026) Figure 19. Middle East and Africa Metagenomics in Healthcare Revenue (USD Million) and Growth Rate (2016-2026) Figure 20. Metagenomics in Healthcare Market Drivers Figure 21. Metagenomics in Healthcare Market Restraints Figure 22. Metagenomics in Healthcare Market Trends Figure 23. Illumina Recent Developments and Future Plans Figure 24. QIAGEN Recent Developments and Future Plans Figure 25. PerkinElmer Recent Developments and Future Plans Figure 26. Thermo Fisher Scientific Recent Developments and Future Plans Figure 27. Oxford Nanopore Technologies Recent Developments and Future Plans Figure 28. Global Metagenomics in Healthcare Revenue Share by Players in 2020 Figure 29. Metagenomics in Healthcare Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure 30. Global Top 3 Players Metagenomics in Healthcare Revenue Market Share in 2020 Figure 31. Global Top 10 Players Metagenomics in Healthcare Revenue Market Share in 2020 Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021) Figure 33. Global Metagenomics in Healthcare Revenue Share by Type in 2020 Figure 34. Global Metagenomics in Healthcare Market Share Forecast by Type (2021-2026) Figure 35. Global Metagenomics in Healthcare Revenue Share by Application in 2020 Figure 36. Global Metagenomics in Healthcare Market Share Forecast by Application (2021-2026) Figure 37. North America Metagenomics in Healthcare Sales Market Share by Type (2016-2026) Figure 38. North America Metagenomics in Healthcare Sales Market Share by Application (2016-2026) Figure 39. North America Metagenomics in Healthcare Revenue Market Share by Country (2016-2026) Figure 40. United States Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 41. Canada Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 42. Mexico Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 43. Europe Metagenomics in Healthcare Sales Market Share by Type (2016-2026) Figure 44. Europe Metagenomics in Healthcare Sales Market Share by Application (2016-2026) Figure 45. Europe Metagenomics in Healthcare Revenue Market Share by Country (2016-2026) Figure 46. Germany Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 47. France Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 48. United Kingdom Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 49. Russia Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 50. Italy Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 51. Asia-Pacific Metagenomics in Healthcare Sales Market Share by Type (2016-2026) Figure 52. Asia-Pacific Metagenomics in Healthcare Sales Market Share by Application (2016-2026) Figure 53. Asia-Pacific Metagenomics in Healthcare Revenue Market Share by Region (2016-2026) Figure 54. China Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 55. Japan Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 56. South Korea Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 57. India Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 58. Southeast Asia Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 59. Australia Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 60. South America Metagenomics in Healthcare Sales Market Share by Type (2016-2026) Figure 61. South America Metagenomics in Healthcare Sales Market Share by Application (2016-2026) Figure 62. South America Metagenomics in Healthcare Revenue Market Share by Country (2016-2026) Figure 63. Brazil Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 64. Argentina Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 65. Middle East and Africa Metagenomics in Healthcare Sales Market Share by Type (2016-2026) Figure 66. Middle East and Africa Metagenomics in Healthcare Sales Market Share by Application (2016-2026) Figure 67. Middle East and Africa Metagenomics in Healthcare Revenue Market Share by Country (2016-2026) Figure 68. Turkey Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 69. Saudi Arabia Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 70. UAE Metagenomics in Healthcare Revenue and Growth Rate (2016-2026) & (USD Million) Figure 71. Methodology Figure 72. Research Process and Data Source

Purchase Report

Single User 3480
Multi User 5220
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.